Ostolek (Alendronate Sodium Trihydrate)

Alendronate sodium triacetate, the active ingredient in Ostree, is a bisphosphonate presented as a tablet for oral use. It treats osteoporosis and other bone‑resorption disorders in post‑menopausal women and men at risk of fractures.

GNH USA supplies Ostree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Alendronate sodium works on the skeletal system to reduce bone loss and strengthen bone architecture. - Osteoporosis: improves bone mineral density and reduces fracture risk in post‑menopausal women and men. - Paget’s disease of bone: normalises abnormal bone remodeling and alleviates bone pain. - Glucocorticoid‑induced osteoporosis: counteracts steroid‑related bone loss and helps maintain skeletal strength.

Alendronate sodium may cause a range of adverse reactions, from mild gastrointestinal discomfort to rare but serious complications.

Common Side Effects: - Upper abdominal pain: mild discomfort after oral intake. - Nausea: occasional feeling of queasiness. - Dyspepsia: indigestion or heartburn. - Esophageal irritation: soreness or burning in the throat. - Musculoskeletal pain: aches in joints or muscles. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Osteonecrosis of the jaw: exposed bone in the mouth, often after dental procedures. - Atypical femoral fracture: unusual breakage of the thigh bone with minimal trauma. - Severe esophageal ulceration: deep sores that may cause bleeding. - Acute phase reaction: fever, myalgia, and flu‑like symptoms after the first dose. - Hypocalcaemia: low blood calcium levels, potentially causing muscle cramps or cardiac arrhythmia.

Before initiating therapy, evaluate renal function, calcium status, and gastrointestinal health. - Assess renal function: avoid use if severe renal impairment is present. - Verify calcium/vitamin D intake: ensure adequate supplementation to reduce hypocalcaemia risk. - Review esophageal disorders: patients with active esophagitis should not take oral bisphosphonates. - Counsel on administration: swallow tablet with a full glass of water, remain upright for at least 30 minutes. - Monitor for atypical fractures: advise patients to report any new thigh or groin pain. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Alendronate sodium can interact with several medicines that affect calcium balance or gastrointestinal absorption.

Major Interactions (Avoid): - Calcium‑containing antacids: reduce alendronate absorption; separate dosing by at least 30 minutes. - Proton‑pump inhibitors (e.g., omeprazole): may diminish drug bioavailability. - Oral bisphosphonates taken concurrently: increase risk of gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Corticosteroids: may exacerbate bone loss, requiring closer monitoring of bone density. - Loop diuretics (e.g., furosemide): can predispose to hypocalcaemia; monitor serum calcium. - Vitamin D analogues: adjust dosing to avoid hypercalcemia when combined with high‑dose vitamin D.